WO2002042419A2 - Cell culture apparatus and methods of use - Google Patents
Cell culture apparatus and methods of use Download PDFInfo
- Publication number
- WO2002042419A2 WO2002042419A2 PCT/US2001/043718 US0143718W WO0242419A2 WO 2002042419 A2 WO2002042419 A2 WO 2002042419A2 US 0143718 W US0143718 W US 0143718W WO 0242419 A2 WO0242419 A2 WO 0242419A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell culture
- cells
- culture apparatus
- cell
- gas permeable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/04—Flat or tray type, drawers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/22—Transparent or translucent parts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/24—Gas permeable parts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/50—Means for positioning or orientating the apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
Definitions
- the present invention generally relates to an apparatus and methods for growing cells or tissue culture in vitro. More particularly, the present invention relates to a cell culture apparatus containing at least one gas permeable membrane which allows rapid and uniform transfer of gases between the environment of cells contained in the cell culture container apparatus and the atmosphere of the incubator in which the cell culture apparatus is incubated.
- the culture of the cells is generally under conditions of controlled pH, temperature, humidity, osmolarity, ion concentrations, and exchange of gases. Regarding the latter, oxygen and carbon dioxide (CO 2 ) are of particular importance to the culturing of cells.
- CO 2 oxygen and carbon dioxide
- an incubator is provided in which CO is infused to maintain an atmosphere of about 5% CO 2 within the incubator.
- the CO 2 interacts with the tissue culture medium, particularly its buffering system, in maintaining the pH near physiologic levels.
- Conventional cell culture containers comprise tissue culture flasks, tissue culture bottles, and tissue culture plates.
- Entry of CO 2 from the incubator atmosphere into a tissue culture plate generally involves a loosely fitting cover which overhangs the plate in excluding particulate contaminants from entering the plate chamber(s), but allows gas exchange between the incubator atmosphere and the atmosphere within the tissue culture plates.
- a loosely fitting cap excludes particulate contaminants from entering the chamber of the flask or bottle, but allows gas exchange between the incubator atmosphere and the atmosphere within the flask or bottle.
- a cap is provided with a gas penrieable membrane or filter, thereby allowing for gas exchange with a tightly fitting cap.
- the culturing of cells is dependent upon the ability to supply to the cells a sufficient amount of oxygen necessary for cell respiration and metabolic function.
- the supply of oxygen for cell respiration in conventional cell culture containers is in the header space of the container, e.g., the void space in the container that is above the surface of the tissue culture medium.
- Efforts to increase oxygen concentration to the cultured cells includes mechanical stirring, medium perfusion or aeration, increasing the partial pressure of oxygen, and/or increasing the atmospheric pressure.
- the volume or surface provided for gas exchange as relative to the volume or surfaces of the whole container, is either inefficiently used and/or results in limiting the rate of gas exchange or in the equilibration of gases.
- the present invention provides a cell culture apparatus comprising a frame; at least one membrane which is gas penneable, and wherein the at least one membrane is securedly sealed to (in a leak-proof sealing with) the frame, in forming a culture chamber; and at least one resealable aperture through the frame which allows substances to be introduced into, or withdrawn from, the culture chamber.
- the cell culture apparatus comprises a frame over which is extended and securedly sealed thereto a gas permeable membrane, and which contains an additional surface comprising a solid plastic surface in forming a culture chamber therebetween.
- the frame is sufficiently rigid to provide a housing for assembling the cell culture apparatus of the present invention.
- the membrane is of suitable thickness to provide sufficient gas penneability to accommodate cell growth in the chamber, and to provide sufficient structural integrity for handling the apparatus. Further, the membrane is of a sufficient optical transparency and clarity so as to observe the cell culture (e.g., the color of the tissue culture medium; and cellular characteristics such as growth and morphology of cells, as observable by microscopy).
- the frame has at least one resealable aperture, and preferably at least two resealable apertures, which allows substances to be introduced into, or withdrawn from, the culture chamber.
- Each aperture comprises an opening through the frame which may serve as a passageway into which is guided a portion of an instrument (e.g., needle or pipette or pipette tip) for introducing a substance into or withdrawing a substance from the culture chamber.
- an instrument e.g., needle or pipette or pipette tip
- the frame is of sufficient thickness and the apertures are of a sufficient limiting diameter to prevent the instrument portion, when inserted through a resealable aperture of the frame, from puncturing either of the walls formed by the membranes of the culture chamber.
- the cell culture apparatus provides an unexpected combination of properties including gas exchange and equilibrium, oxygenation of cells cultured in the apparatus, optical transparency and clarity for observing cell culture and cell characteristics during culture, an attachment surface and conditions which promote even distribution of anchorage dependent cells, spatial efficiency, versatility, and conditions which can promote a high rate of cell growth in achieving a high cell density in a relatively short period of time as compared to conventional cell culture devices.
- FIG. 1 is a top plan view of an embodiment of a cell culture apparatus according to the present invention.
- FIG. 2 is a cross-sectional view taken along line 2-2 of the cell culture apparatus illustrated in FIG. 1;
- FIG. 3 is a side view of an embodiment of the cell culture apparatus according to the present invention.
- FIG. 4 is a perspective view of a cell culture apparatus showing an embodiment wherein a sample is introduced or withdrawn from the culture chamber;
- FIG. 5 is a perspective view of another embodiment of the cell culture apparatus according to the present invention
- FIG. 6 is a top view of another embodiment of the cell culture apparatus according to the present invention.
- FIG. 7 is a top view of another embodiment of the cell culture apparatus according to the present invention.
- FIG. 8 is a perspective view of a cell culture apparatus showing removal of a magnetic sheet assembly which is detachably secured in adhesive contact to the cell culture apparatus.
- gas permeable membrane is used herein, for the purposes of the specification and claims, to mean a biocompatible material which is liquid impermeable, which is capable of allowing transfer of gases into and out of the cell culture chamber, and which is capable of excluding microbial contamination (e.g., pore size is sufficiently small enough to exclude passage of microbes commonly encountered in contamination of cell cultures), and which is optically transparent and clear for permitting observation of the cell culture (e.g., of the color of the tissue culture medium which contains a pH indicator; and of cultured cell characteristics such as growth and morphology of the cells as detectable by light microscopy), as will be described in more detail herein.
- microbial contamination e.g., pore size is sufficiently small enough to exclude passage of microbes commonly encountered in contamination of cell cultures
- optically transparent and clear for permitting observation of the cell culture (e.g., of the color of the tissue culture medium which contains a pH indicator; and of cultured cell characteristics such as growth and morphology of the cells as detectable by light microscopy
- Thickness of the gas permeable membrane will depend on the desired resultant characteristics which may include, but are not limited to, structural integrity, degree of gas permeability, and rate of transfer of gases.
- the thickness of a gas permeable membrane can range from less than about 0.00125 inches to about 0.005 inches. In a preferred embodiment, the thickness of the membrane is in the range of about 0.002 inches to about 0.004 inches, and in a more preferred embodiment, 0.004 inches.
- the gas permeable membrane may be comprised of one or more membranes known in the art.
- Membranes typically comprise suitable polymers that may include polystyrene, polyethylene, polycarbonate, polyolefin, ethylene vinyl acetate, polypropylene, polysulfone, poly-tetrafluoroethylene, or a silicone copolymer.
- the choice of the composition of the gas permeable membrane will depend on the type of cell to be cultured (e.g., cells which grow attached (anchorage-dependent), cells which grow in suspension (anchorage-independent), cells that may grow as attached or in suspension), degree of gas permeability, rate of transfer of gases, and optical transparency and clarity, hi a more preferred embodiment, the gas permeable membrane has been treated, on a side of the membrane which may serve as a surface for attachment of anchorage-dependent cells in culture, by ionization to improve adhesion of the treated membrane surface to anchorage- dependent cells.
- Ionization of the membrane may render the treated membrane surface more hydrophilic, and can be performed using methods known in the art which include plasma discharge, corona discharge, gas plasma discharge, ion bombardment, ionizing radiation, and high intensity UN light.
- the gas permeable membrane is not treated by ionization.
- the gas permeable membrane is a single membrane comprised of polystyrene or polypropylene, is treated on at least one side by corona treatment, and is about 0.004 inches thick.
- the at least one gas penneable membrane of the cell culture apparatus has the following gas permeability characteristics with respect to oxygen and carbon dioxide gases: permeability performance at 1 atmosphere and at 37°C for O 2 is in the range of from about 15 to about 40 Barrers, and more preferably about 23 Barrers; and penneability perfonnance at 1 atmosphere and at 37°C for CO 2 is in the range of from about 80 to about 95 Barrers, and more preferably about 88 Barrers.
- optically transparent and clear is used herein, and in relation to characteristics of a gas permeable membrane and for observation of cells cultured in the cell culture apparatus according to the present invention, for the purposes of the specification and claims, to mean that a gas permeable membrane is clear and transparent, and more preferably: is transparent in the spectrum range of from about 250 nm to about 900 nm; lacks fluorescence under excitation light when the excitation light has a spectrum in the range of from about 260 nm to about 700 nm; and has a sharper diffraction image as compared to the diffraction image of a conventional, plastic tissue culture flask or tissue culture plate.
- an indelible black ink marker was used to draw a line of about 1 mm in width on both the gas permeable membrane of a cell culture apparatus according to the present invention, and the hard plastic surface of a tissue culture flask.
- the line observed on the gas permeable membrane remained a well-defined line of about 1 mm.
- a diffused image of the line was observed on the tissue culture flask surface; i.e., the width of the line observed was approximately 3 mm, with the main line being surrounded by dark shadows in which contrast was lost.
- the tissue culture flask surface demonstrated a diffraction image that is at least 100% greater than that observed for the membrane surface of the cell culture apparatus according to the present invention.
- the term "magnetic sheet assembly" is used herein, for purposes of the specification and claims, to mean an assembled combination comprising, in structural order, a magnetic sheet, a permanent adhesive, a carrier sheet, and a non-permanent adhesive which together is particularly adapted to permit ready adhesion to and removal from a surface of the cell culture apparatus according to the present invention in an application for magnetic separation.
- the magnetic sheet assembly may further comprise a layer in contact with the magnetic sheet on a side opposite to the permanent adhesive, wherein the layer may be a material selected from the group consisting of a protective coating, a label, and a combination thereof.
- Various protective coatings for magnets are known in the art to include, but are not limited to, polyurethane, a polyurethane rubber compound, polyester, polyester-imide, polyamide, and the like; and may further comprise a colorant.
- a preferred magnetic sheet assembly is described in more detail in United States patent application No. 09/723,008, filed 27 NOV 00, the disclosure of which is herein incorporated by reference.
- a magnetic sheet comprises at least one substantially flat magnetic sheet having the following characteristics: (a) a surface magnetic field having a field strength, as measured by a gaussmeter, in a range of from about 250 to about 1500 gauss, and more preferably in a range of from about 450 to about 1200 gauss; (b) sufficient flexibility to permit the magnetic sheet, as part of an assembly, to be separated from the cell culture apparatus to which it is removably adhered by pulling the magnetic sheet apart from the apparatus; (c) is magnetized with magnetic poles of alternating polarities, which poles being generally arranged as a plurality of parallel, spaced apart lines that are spaced to maximize efficiency of magnetic separation (in a preferred embodiment, 7 to 9 poles per inch), and may further comprise magnetic poles which are positioned to form a combination of a plurality of parallel spaced apart lines and a plurality of perpendicular spaced apart lines in forming a grid pattern for maximizing efficiency of magnetic separation (in a preferred embodiment, 14 to 18 pole
- a magnetic sheet may include, but is not limited to, a sheet consisting of a fine magnetic powder such as barium ferrite loaded into a thermoplastic binder; a sheet of plastics or vinyl material impregnated with a ferromagnetic material; a sheet of synthetic resin material having mixed therein a magnetic powder; magnetic particles embedded in a polymer sheet of typically 0.7 mm or 0.030 inches thickness; a vinyl material including magnetic materials dispersed therethrough; or other suitable material having properties compatible with its intended purpose.
- the magnetic sheet is comprised of a flexible barium ferrite magnet material, or a flexible strontium ferrite magnet material, or a neodymium iron boron bonded magnetic material, or a combination thereof.
- the thickness of the magnetic sheet will vary depending on factors which include, but are not limited to, the composition of the magnetic sheet material, whether the magnetic sheet comprises one or more sheets, the desired field strength, and the spacing of the magnetic poles.
- the thickness of the magnetic sheet may range from about 0.2 mm to about 5 mm.
- a preferred thickness of a suitable commercially available, flexible strontium ferrite-based material of from about 450 Gauss to about 1000 Gauss is in a range of from about 0.03 to about 0.06 inches.
- a pressure sensitive permanent adhesive is provided to fixedly bond the magnetic sheet to the pressure sensitive adhesive laminate comprising the pressure sensitive permanent adhesive, the carrier sheet, and the pressure sensitive non- permanent adhesive.
- pressure sensitive pennanent adhesives are well known in the art, are commercially available from adhesive manufacturers, and include, but are not limited to, acrylic base adhesives, rubber based adhesives, and the like.
- a typical thickness of the pressure sensitive permanent adhesive or the pressure sensitive non-permanent adhesive may be in a range of from about 0.0003 to about 0.003 inches; and more preferably, is about 0.0005 inches.
- the pressure sensitive permanent adhesive and pressure sensitive non-permanent adhesive may be applied to a respective separate side of the carrier sheet, in fabricating the double-sided pressure sensitive adhesive laminate, by any conventional method known in the art such as by coating (e.g., brush coating, knife coating, transfer coating, roll coating, and the like), dispersion, spraying, calendaring, and the like.
- the pressure sensitive non-pennanent adhesive is: (a) of sufficient cohesion to keep the magnetic sheet assembly in adhesive contact with the surface of the cell culture apparatus for a prescribed period of time necessary for a magnetic separation process to be initiated and completed (typically a time in a range of from about 10 minutes to about 4 hours); and (b) is of a light to moderate tack to permit the magnetic sheet assembly to be lifted (e.g., peeled) from the cell culture apparatus to which it was in close adhesive contact, wherein the non- permanent adhesive releases clearly (0% to less than 5% of the surface covered by the adhesive retains any visible adhesive residue upon removal) from the surface of the cell culture apparatus as the magnetic sheet assembly is removed.
- the carrier sheet may be selected from a variety of carrier sheet materials suitable for use with pressure-sensitive adhesive products.
- the carrier sheet is generally thin and flexible, and preferably the carrier sheet has a thickness in the range of from about 0.03 mm to about 0.25 mm; and more preferably, the carrier sheet has a thickness of about 0.002 inches.
- the carrier sheet material may be fibrous, non- fibrous, or a combination thereof.
- the carrier sheet may be a suitable polymeric film, fabric (e.g., nylon), paper, cellulose, and the like; and may preferably include, but is not limited to, a polystyrene, an acrylic polymer (e.g., polymethylmethacrylate), a vinyl polymer (e.g., vinyl chloride or ester, plasticized vinyl polymer, and the like), a polycarbonate, a polyolefin, a polyester, a cellulose acetate.
- a polystyrene an acrylic polymer (e.g., polymethylmethacrylate)
- a vinyl polymer e.g., vinyl chloride or ester, plasticized vinyl polymer, and the like
- a polycarbonate e.g., a polyolefin
- polyester e.g., cellulose acetate
- septum is used herein, for the purposes of the specification and claims, to mean a pre-slit septum comprised of an elastomeric material dimensioned to cause centrally directed compression, when inserted in an access port configured to accommodate the septum, such that: when a tip is inserted into and accesses the slit of the septum-access port assembly, the slit closes around and sealingly engages the outer surface of a tip accessing the septum to prevent leakage between the tip and slit so as to maintain a leak-proof seal; and enhances the ability of the septum to reseal itself ("resealability") after withdrawal of the tip from the slit, even after the septum has been repeatedly accessed by tips.
- resealability enhances the ability of the septum to reseal itself
- the septum may further comprise one or more additives such as a colorant, filler, and the like.
- the elastomeric material may be natural or synthetic and may be a material including, but not limited to, silicone rubber, fluorocarbon rubber, butyl rubber, polychloroprene rubber, a silicone elastomer composite material, thermoplastic elastomer, medical grades of silicone rubber, polyisoprene, a synthetic isoprene, and a combination thereof.
- the elastomeric material may be selected to have a Shore A durometer within the range of from about 30 to about 80.
- the septum comprises an elastomeric material and an antimicrobial agent mixed and formed into the elastomeric septum, wherein the antimicrobial agent becomes incorporated into the elastomeric septum and forms a surface coating on the elastomeric septum, and wherein the antimicrobial agent exhibits migration through the elastomeric septum as the surface coating of antimicrobial agent is depleted.
- Suitable and exemplary broad spectrum antimicrobial agents may include, but are not limited to, triclosan (2,4,4 '-trichloro-2'hydroxydiphenyl ether), 5-chloro-2-(2,4-dichlorophenoxy)phenol, and 2- 2'-methylene-bis-4-chlorophenol, 3-(trifluomethyl)-4,4'-dichloro-carbanilide, or polyhexamethylene biguanide hydrochloride.
- tissue culture medium is used herein, for the purposes of the specification and claims, to mean a liquid solution which is used to provide sufficient nutrients (e.g., vitamins, amino acids, essential nutrients, salts, and the like) and properties (e.g., osmolarity, buffering) to maintain living cells (or living cells in a tissue) and support their growth.
- nutrients e.g., vitamins, amino acids, essential nutrients, salts, and the like
- properties e.g., osmolarity, buffering
- the cell culture apparatus 12 comprises frame 18.
- Frame 18 may be of a basic biocompatible composition that may comprise suitable plastic, thermoplastic, synthetic, or natural materials which can be fabricated into a framework structure, thereby achieving the required structural integrity for its intended purpose. It should be apparent to those skilled in the art that a wide latitude of choice can be exercised in selecting a material suitable for formation and/or fabrication of frame 18.
- cell culture apparatus 12 may depend on one or more factors including, but not limited to, the desired fluid capacity of the culture chamber fonned therewith, and the dimensions of the culture chamber, hi a prefened embodiment, cell culture apparatus 12 is of a general shape and size to be able to be accommodated, and be substantially held in position, by a standard mechanical stage specimen holder for a microscope.
- cell culture apparatus 12 has a length in a range of from about 10 cm to about 13.5 cm, a width in a range of from about 7 cm to about 9 cm, and a height in a range of from about 0.2 cm to about 2.0 cm; and more preferably is about 12.6 cm in length by about 8.4 cm in width by about 0.5 cm in height; providing a cell culture apparatus which permits culturing of cells in less incubator space than would be required for culturing cells at a comparable growth rate or to a comparable cell density using a conventional cell culture device, hi a prefened embodiment, and in referring to FIGS. 1 & 4-7, a beveled portion 14 of frame 18 slopes at an angle (e.g., at a degree in a range of from about 25° to about 40°), in relation to the plane of the at least one gas permeable membrane.
- an angle e.g., at a degree in a range of from about 25° to about 40°
- frame 18 is a housing shaped to accommodate the aligning, contacting and securing thereto (in a leak-proof sealing) gas permeable membrane 31 in assembling cell culture apparatus 12 of the present invention.
- Frame 18 may further comprise a box-like housing.
- another surface 32 which forms a wall of cell culture chamber 40.
- Surface 32 is a rigid surface preferably fo ned as part of frame 18 by a single molding operation, and preferably comprises a high-density resinous material which may include, but is not limited to, polyethylene, polypropylene, polyvinylchloride, or other plastic suitable for cell culture applications.
- Surface 32 is liquid impermeable and gas impermeable.
- Membrane 31 may be secured to frame 18 in a leak-proof sealing using means that may include mechanical means, chemical means (an adhesive agent which may include, but is not limited to, a pressure-sensitive acrylic adhesive, hot-melt adhesive, rubber cement, or any other form of adhesive or bonding agent useful for the purposes attendant to the present invention), or other suitable means.
- adhesive agent which may include, but is not limited to, a pressure-sensitive acrylic adhesive, hot-melt adhesive, rubber cement, or any other form of adhesive or bonding agent useful for the purposes attendant to the present invention
- other suitable means may include one or more of heat bonding, sonic welding, pressure fit sealing in forming a leak- proof seal, and a molding process in which the membranes become an integral part of the frame (e.g., by extrusion).
- the membrane is secured to the frame by a sonic welding process which comprises cutting the frame and bonding (melting) the membrane to substantially the cut portion of the frame in a manner which results in a leak- proof sealing between the membrane secured to the frame in the formation of a culture chamber, in a process of assembling the cell culture apparatus according to the present invention.
- membrane 31 (or a portion thereof) may be removed from frame 18 so as to facilitate further manipulations of cells cultured in the culture chamber of the cell culture apparatus according to the present invention.
- membrane 31, to which is attached the anchorage-dependent cells is removed from the frame by cutting it or peeling it away from the frame.
- the membrane does not serve as the attachment surface for anchorage-dependent cells (e.g., surface 32 serves as the attachment surface) but is cut or peeled from the frame so as to access the culture chamber 40 and the cells contained therein.
- the membrane may then be directly stained using standard dyes or stains, and methods for staining known to those skilled in the art.
- the attached cells may be stained for analysis by fluorescence microscopy, phase contrast microscopy, Nomarsky contrast microscopy, scanning electron microscopy, and imaging (e.g., photography or digital imaging) associated therewith.
- the attached cells may be gently scraped off membrane 31 or surface 32 (depending which serves as the attachment surface) in circumstances where it is desirable to harvest the cells off of the membrane without enzyme treatment (e.g. trypsinization).
- Such circumstances may include further use or analysis of the harvested cells where a trypsin-sensitive cell surface molecule is needed to be intact; e.g., for immediate, further analysis such as in flow cytometric analysis, or in a functional bioassay (e.g., cell cytotoxicity assay).
- frame 18 has at least one aperture 23, and preferably at least two apertures.
- aperture 23 of frame 18 may serve as a passageway into which is guided an instrument for introducing a substance into, or withdrawing a substance from, or venting from, the culture chamber.
- the diameter of each aperture 23 is sufficient to allow for entry of that portion of the instrument (for reference purposes only, refened to hereinafter as "tip" of the instrument) which is necessary for its intended purpose of introducing a substance into, or withdrawing a substance from, or venting from, the culture chamber.
- the diameter of each aperture 23 will depend on the type of instrument being used for the intended purpose, and the size of the tip of the instrument.
- each aperture 23 is sufficient to allow the tip to pass therethrough (e.g., about 1 mm to about 2 mm in diameter).
- the tip of the instrument is guided through aperture 23 of frame 18, and introduced into culture chamber 40.
- the frame is of sufficient thickness and one or more of apertures 23 are of a sufficient limiting diameter to prevent the tip of the instrument, when inserted through aperture 23, from contacting and puncturing either of the walls of the culture chamber 40 formed by membrane 31 and surface 32.
- the at least one aperture 23 is resealable by a suitable means known in the art; e.g., a cap, a plug, a septum, or other suitable means.
- aperture 23 is substantially (partially or completely) filled and sealed with a septum 36, and more preferably with a septum 36 comprising an elastomeric material and an antimicrobial agent as previously described herein in more detail.
- the gas permeable membrane forms a portion in the range of from about 10% to about 100%> of a surface forming the wall of the culture chamber in the cell culture apparatus according to the present invention
- FIGS. 1, & 8 show a gas permeable membrane comprising the entire surface of a wall forming culture chamber 40.
- FIGS. 5 & 6 show a single gas permeable membrane forming about 10%) and about 60%>, respectively, of the surface of a wall forming culture chamber 40.
- FIG. 7 illustrates a plurality of gas permeable membranes which together form about 50% of the surface of a wall forming culture chamber 40.
- the gas permeable membrane provides an attachment surface which provides for a higher density of, and spatial efficiency for, anchorage- dependent cell growth. This is an advantage over conventional cell culture containers which have been reported to exhibit non-uniform gas exchange over the respective attachment surface; and hence, a variability in the ability of cells to grow depending on their spatial relation to the gradient of gas exchange.
- the distance between membrane 31 and surface 32 depends on the size (e.g., the height) of frame 18.
- the average distance between membrane 31 and surface 32 is in a range of from about 0.05 to about 0.5 inches.
- the average distance between membrane 31 and surface 32 is a distance in the range of from about 0.07 to about 0.08 inches.
- anchorage-dependent cells are cultured in the cell culture apparatus with membrane 31 as the surface to which the anchorage-dependent cells may attach, and is a surface which provides uniform gas exchange.
- anchorage-dependent cells may be introduced into the cell culture apparatus, and the cells introduced are incubated a sufficient time (depending on the cell type) to allow settling by gravity, and attachment of the cells to gas permeable membrane 31.
- the cell culture apparatus may then be rotated 180° so that the inverted cells are grown in a culture as suspended from membrane 31. Additional cells may then be seeded on surface 32.
- membrane 31 is optically transparent and clear; e.g., in facilitating observations of changes in the color of the medium's pH indicator typically observed during cell culture, and of cellular characteristics (e.g., growth and morphology of cells such as by microscopy).
- a bioreactor comprises a plurality of the cell culture apparatuses according to the present invention which are operatively linked by providing a fluid passageway connecting the culture chambers of the plurality of cell culture apparatuses.
- each of the plurality of the cell culture apparatuses may be interconnected with another cell culture apparatus by a connecting passageway that allows for the flow of tissue culture medium through the passageway and between the culture chambers of the interconnected cell culture apparatuses.
- a connecting passageway that allows for the flow of tissue culture medium through the passageway and between the culture chambers of the interconnected cell culture apparatuses.
- One needle would be inserted into a resealable aperture 23, through the frame, and into a culture chamber of the first cell culture apparatus; and the second needle would be inserted into a resealable aperture 23, through the frame, and into a culture chamber of a second cell culture apparatus.
- a piece of tubing may then have one open end operatively connected to the first needle, and the opposite open end of the tubing operatively comiected to the second needle.
- the tubing located between and operatively connected to the two needles, provides fluid flow communication between the culture chamber of the first cell culture apparatus and the culture chamber of the second cell culture apparatus.
- a plurality of the cell culture apparatuses may be operatively connected in forming a bioreactor.
- the cell culture apparatus to culture cells, whether the cells are individual cells (cells which are grown independent of forming a structure such as a tissue; an illustrative example being a cell line), or cells forming a tissue (typically, a mesh or network of cells, with their intercellular substance in forming a structured or organized tissue), or a combination thereof.
- individual cells which can be cultured in the cell culture apparatus comprise one or more cell types including, but not limited to, animal cells, insect cells, mammalian cells, human cells, transgenic cells, genetically engineered cells, transformed cells, cell lines, anchorage-dependent cells, and anchorage-independent cells.
- tissue formed by cells in culture can also be cultured in the cell culture apparatus according to the present invention.
- the cell culture apparatus of the present invention is generally not limited to a specific type of cell to be cultured, nor the tissue culture medium capable of sustaining cell growth as long as the medium provides sufficient nutrients and properties (e.g., osmotic pressure) to maintain and support cell growth.
- the cell culture apparatus prior to use for culturing cells, the cell culture apparatus in sterilized using a method conventional in the art. In a prefened embodiment, the cell culture apparatus is sterilized by exposure to gamma radiation.
- anchorage-dependent cells are cultured in the cell culture apparatus according to the present invention.
- either membrane 31, or surface 32, or both has an inner face (forming an inside surface of the culture chamber) which is of sufficient hydrophilicity for promoting adhesion of cells desired to be cultured; and therefore, can act as a surface to which the cells can attach and grow.
- the at least one membrane 31 may have inherent chemical properties which promote such adhesion, or the inner face may be treated (e.g., electrically, ionically, or chemically) to promote such adhesion.
- Such treatment may include one or more of chemically etching of the inner surface, ionization of the inner surface, or coating the inner surface with a suitable coating reagent.
- suitable coating reagents are known to those skilled in the art to include gelatin, collagen, fibronectin, an adhesion protein, an adhesion peptide (see, e.g., PCT/US95/00817).
- a method of culturing cells using the cell culture apparatus 12 comprises suspending the cells to be cultured (e.g., anchorage-dependent cells or anchorage-independent cells) in an appropriate amount of tissue culture medium to support cell growth, in fonning a suspension; introducing the suspension into a suitable instrument (e.g., a syringe and blunt tip combination) for injecting the suspension into the cell culture apparatus 12; using sterile (aseptic) technique, and inserting a portion (e.g., the tip of a needle) of the instrument through a resealable aperture 36 (septum and aperture combination) and into the cell culture chamber 40 of the cell culture apparatus 12; expelling the suspension from the instrument (e.g., from the chamber of a syringe and through the tip) and into the cell culture chamber; withdrawing the tip from the cell culture apparatus; and incubating the cell culture apparatus, containing the suspension of medium and cells (e.g., in a cell culture incubator or in conditions sufficient for cell growth
- a substance that may be introduced into the culture chamber 40 of the cell culture apparatus 12 may include one or more of tissue culture medium alone, tissue culture medium with cells, cells suspended in a physiological buffer, and a drug or cytokine or growth factor or enzyme (e.g., solution of trypsin) or other biological agent to treat cells cultured therein.
- tissue culture medium alone, tissue culture medium with cells, cells suspended in a physiological buffer, and a drug or cytokine or growth factor or enzyme (e.g., solution of trypsin) or other biological agent to treat cells cultured therein.
- a drug or cytokine or growth factor or enzyme e.g., solution of trypsin
- the cell culture chamber 40 may be filled completely with tissue culture medium or other suitable growth medium for culturing cells or tissue desired to be grown.
- the cell culture apparatus 12 according to the present invention can be filled in a manner wherein a substantial head space is lacking. Further, the cell culture apparatus 12 of the present invention provides an unexpected capacity for gas equilibrium believed to be due to the enhanced gas exchange exhibited by the use and anangement of one or more gas permeable membranes 31. Together, these features of the cell culture apparatus 12 according to the present invention prevent the abrupt change in initial pH as observed in conventional cell culture containers. By preventing such an abrupt change in pH of the medium, the initial culture conditions attain a pH equilibrium more conducive to optimal cell growth.
- a disadvantage of conventional cell culture containers is that conventional cell culture containers require a head space between the top of the container and the surface of the tissue culture medium.
- the cell culture apparatus may be tilted or gently shaken to mix the medium and cells contained therein, without causing detectable foam formation or cell trauma.
- the at least one gas permeable membrane 31 may be secured taut to the frame so that the membrane is tympanic and thereby facilitates mixing in the filled culture chamber.
- the method comprises suspending anchorage-dependent cells to be cultured in an appropriate amount of tissue culture medium to support cell growth, in forming a suspension; introducing the suspension into a suitable instrument for injecting the suspension into the cell culture apparatus 12 via one or more resealable apertures 23; using sterile (aseptic) technique, and inserting a tip of the instrument through one or more resealable apertures 23 and into the cell culture chamber 40 of the cell culture apparatus 12; expelling the suspension through the tip of the instrument and into the cell culture chamber 40; withdrawing the tip of instrument from the cell culture apparatus 12; and incubating the cell culture apparatus, containing the suspension of medium and cells, for a sufficient time (e.g., 30 minutes to 3 hours, depending on the cell type) to allow the cells to settle by gravity, and contact and attach to the membrane serving as the attachment surface.
- a sufficient time e.g., 30 minutes to 3 hours, depending on the cell type
- the method may further comprise subsequently rotating the cell culture apparatus 180°, and placing the cell culture apparatus in the incubator in a position so that the cells are incubated in an inverted manner in the culture chamber; i.e., the cells are attached to the membrane serving as the upper wall of the culture chamber with respect to the incubator shelf on which the cell culture apparatus rests.
- the cells hang down into the culture chamber, and grow suspended along the surface of the upper membrane. This allows cell debris to fall by gravity, from the suspended culture, to the lower surface where such separated cell debris may be easily removed from the culture chamber by aspiration and or a washing step.
- the cell culture apparatus may also be used for magnetic separation applications, hi this example, illustrated are various embodiments wherein the cell culture apparatus further comprises a magnetic sheet detachably secured thereto.
- a magnetic sheet assembly 51 is extended over and detachably secured to cell culture apparatus 12 in a face to face manner such that the magnetic sheet is placed in a position so as to be in adhesive contact with substantially all (all or that portion of the membrane which forms a wall of culture chamber 40 of the surface of the at least one gas permeable membrane 31 of the cell culture apparatus.
- the magnetic sheet assembly 51 may be detachably secured to the cell culture apparatus 12 in a manner for magnetic particles placed within the culture chamber 40 to be attracted to, and held into position (along the inside wall of culture chamber 40 comprising the inner surface of the membrane 31) by, the magnetic field strength of the detachably secured magnetic sheet assembly 51.
- magnetic sheet assembly 51 has a form generally co-dimensional with the surface 32 to which it is placed in adhesive contact, hi a method of magnetic separation using the cell culture apparatus 12 having detachably secured thereto a magnetic sheet assembly 51, and using methods described in the previous Examples herein, introduced into the culture chamber are: (a) a fluid containing a mixed population of cells in which there is a population of target cells (e.g., the cell type desired to be isolated from the fluid containing the mixed population of cells types); and (b) a magnetic separation reagent comprising magnetic particles coated with a ligand, wherein the ligand has sufficient binding specificity and affinity for the cells desired to be separated and for achieving magnetic separation.
- a fluid containing a mixed population of cells in which there is a population of target cells (e.g., the cell type desired to be isolated from the fluid containing the mixed population of cells types); and (b) a magnetic separation reagent comprising magnetic particles coated with a ligand, wherein the ligand has sufficient binding specificity and affinity
- the magnetic separation reagent contacts and binds, via the ligand coating, with target cells present in the fluid in forming complexes.
- the fluid containing the mixed population of cells, and the magnetic separation reagent may be mixed first, and then the mixture is introduced in the cell culture apparatus for performing the magnetic separation.
- complexes formed are drawn to (by magnetic attraction), and contact the wall of culture chamber 40 comprising the inner face of the membrane, along the plane of cell culture apparatus 12 to which is detachably secured the magnetic sheet.
- the fluid is removed from the cell culture apparatus 12.
- the removed fluid is utilized because it has been depleted of a specific cell population.
- the removed fluid contains substantially all of the (unwanted) remainder of the mixed cell populations.
- culture chamber 40 may be washed with a solution (e.g., tissue culture medium or physiological solution) to remove any remaining unbound cells, while the target cells remain bound, via magnetic attraction, as part of the complex with the magnetic separation reagent.
- the appropriate amount and type of tissue culture medium relative to that cell type is then introduced into the culture chamber 40; the magnetic sheet assembly 51 is then removed (e.g., by a pulling or peeling action, as illustrated in FIG. 8) from the cell culture apparatus 12, thereby removing the magnetic force holding the complexes in place in the cell culture chamber 40, and thereby releasing the complexes into the medium; and then the cell culture apparatus 12 is placed into and incubated in a cell culture incubator.
- the cell culture apparatus 12 may also be used for applications in which recombinant DNA molecules are introduced into cultured cells, hi this example, illustrated is the use of the cell culture apparatus 12 in which a vector is introduced into the cells by introducing an effective amount of the vector (for introduction into the cultured cells) into the cell culture apparatus 12 so that the vector contacts the cultured cells contained in the culture chamber 40 of the cell culture apparatus 12.
- the methods used for introducing a substance into the cell culture apparatus 12, as described in Example 2 herein, may also be used to introduce the vector into the cell culture apparatus 12.
- the vector may comprise a plasmid vector, viral vector, expression vector, or a combination thereof.
- the vector may comprise a recombinant DNA molecule comprising the vector operatively linked (e.g., to a promoter) to a desired DNA molecule to be expressed by cells containing the vector.
- a recombinant DNA molecule comprising the vector operatively linked (e.g., to a promoter) to a desired DNA molecule to be expressed by cells containing the vector.
- animal cells and more preferably, mammalian cells
- plant cells are typical cells into which it is desired to introduce a recombinant DNA molecule such as an expression vector for promoting expression of a desired gene into a gene product in the cells.
- cultured cells contained in the cell culture apparatus 12 may be incubated with a mixture comprising an amount of a recombinant DNA molecule desired to be introduced into the cells, and a transfection reagent.
- the DNA molecule is mixed with the transfection reagent and the mixture comprising tissue culture medium, transfection reagent and vector is introduced tlirough the aperture 23 and expelled into the culture chamber 40 so as to contact the adherent, cultured cells.
- the cell culture apparatus 12 may then be incubated overnight at 37°C in 5% CO 2 so that the contact between the cultured cells and the mixture (comprising the tissue culture medium and transfection reagent and vector) promote the uptake by and introduction into cultured cells of the vector.
- the tissue culture medium may then be removed from the cell culture apparatus 12, and replaced with fresh tissue culture medium.
- Transfection efficiency may then be determined using a conventional method known in the art, and as enabled by the vector used. As will be apparent to one skilled in the art, the transfection efficiency may be increased depending on factors which include, but are not limited to, the type of cells into which it is desired to introduce the vector, optimization of the conditions for transfection (e.g., the amount of DNA per number of cells, the medium used for transfection, the time of the transfection process), and the type and amount of transfection reagent used. Also, it will be apparent to one skilled in the art that using similar steps, a vector may also be introduced into anchorage-independent cells cultured in the cell culture apparatus 12 according to the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002230459A AU2002230459A1 (en) | 2000-11-21 | 2001-11-21 | Cell culture apparatus and methods of use |
| JP2002545125A JP2004514432A (en) | 2000-11-21 | 2001-11-21 | Cell culture device and method of use |
| EP01990694A EP1346028A4 (en) | 2000-11-21 | 2001-11-21 | Cell culture apparatus and methods of use |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71765100A | 2000-11-21 | 2000-11-21 | |
| US72300800A | 2000-11-27 | 2000-11-27 | |
| US09/723,008 | 2000-11-27 | ||
| US09/724,153 US6410309B1 (en) | 1999-03-23 | 2000-11-28 | Cell culture apparatus and methods of use |
| US09/724,153 | 2000-11-28 | ||
| US09/975,889 US6749750B2 (en) | 2000-11-27 | 2001-10-11 | Magnetic sheet assembly for magnetic separation |
| US09/975,889 | 2001-10-11 | ||
| US09/717,651 | 2001-11-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2002042419A2 true WO2002042419A2 (en) | 2002-05-30 |
| WO2002042419A3 WO2002042419A3 (en) | 2002-10-24 |
Family
ID=40169583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/043718 Ceased WO2002042419A2 (en) | 2000-11-21 | 2001-11-21 | Cell culture apparatus and methods of use |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP2230297B1 (en) |
| JP (2) | JP2004514432A (en) |
| AU (1) | AU2002230459A1 (en) |
| WO (1) | WO2002042419A2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083412A1 (en) * | 2003-03-18 | 2004-09-30 | Japan Tissue Engineering Co., Ltd | Method of cell culturing and cell sheet |
| US7514256B2 (en) | 2005-02-11 | 2009-04-07 | Emilio Barbera-Guillem | Bioreactor for selectively controlling the molecular diffusion between fluids |
| EP1935974A4 (en) * | 2005-10-14 | 2012-04-25 | Toyo Seikan Kaisha Ltd | CULTURE TANK AND CULTURE METHOD |
| CN111548938A (en) * | 2020-06-09 | 2020-08-18 | 英诺维尔智能科技(苏州)有限公司 | New high-performance culture flask for mixed culture of suspension and adherent cells |
| US11274273B2 (en) | 2005-07-26 | 2022-03-15 | Corning Incorporated | Multilayered cell culture apparatus |
| US11377635B2 (en) | 2006-12-07 | 2022-07-05 | Wilson Wolf Manufacturing Corporation | Highly efficient gas permeable devices and methods for culturing cells |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4668568B2 (en) * | 2003-08-26 | 2011-04-13 | 株式会社メディネット | Culturing container, culturing apparatus, and cell culturing method |
| JP2007175028A (en) * | 2005-12-28 | 2007-07-12 | Koojin Bio Kk | Closed cell culture container, closed cell culture kit, and method for producing closed cell culture container |
| US10139322B2 (en) | 2012-07-03 | 2018-11-27 | Merck Patent Gmbh | Sample preparation device |
| JP2013143955A (en) * | 2013-03-19 | 2013-07-25 | Cellseed Inc | Supply system for closed culture medium for culturing small cell |
| DE102017213923A1 (en) * | 2017-08-10 | 2019-02-14 | Robert Bosch Gesellschaft Für Medizinische Forschung Mbh | Device for cultivating tissue sections |
| US10377982B1 (en) * | 2019-01-02 | 2019-08-13 | Wei K. Hsu | Cultivation bag for cultivating microbes |
| DE102023201202A1 (en) * | 2023-02-14 | 2024-08-14 | Robert Bosch Gesellschaft Für Medizinische Forschung Mbh | Device for culturing a tissue section |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000056870A1 (en) | 1999-03-23 | 2000-09-28 | Biocrystal Ltd. | Cell culture apparatus and method for culturing cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3915212A (en) * | 1973-12-10 | 1975-10-28 | Abbott Lab | Flexible medical fluid container having a combined fill and administration port and reinforced hanger |
| US4435508A (en) * | 1981-11-20 | 1984-03-06 | Gabridge Michael G | Tissue culture vessel |
| JPS60160881A (en) * | 1984-01-03 | 1985-08-22 | イ−・アイ・デユポン・ド・ネモア−ス・アンド・コンパニ− | Thin film for cell culture chamber |
| US4748124A (en) * | 1984-10-30 | 1988-05-31 | E. I. Du Pont De Nemours And Company | Compartmentalized cell-culture device and method |
| EP0617949A1 (en) * | 1993-03-25 | 1994-10-05 | Pohl GmbH & Co. KG | Infusion bottle |
| DE4309738C1 (en) * | 1993-03-25 | 1994-10-13 | Pohl Gmbh & Co Kg | Closure cap |
| US5707869A (en) | 1994-06-28 | 1998-01-13 | Wolf; Martin L. | Compartmentalized multiple well tissue culture plate |
| US5935847A (en) * | 1994-10-28 | 1999-08-10 | Baxter International Inc. | Multilayer gas-permeable container for the culture of adherent and non-adherent cells |
| US5665599A (en) * | 1994-12-01 | 1997-09-09 | Minuth; Will | Chamber for cultivating cells |
| US5523228A (en) | 1995-07-07 | 1996-06-04 | Hmri/Clmf | Hydrodynamic cell culture environment for three dimensional tissue growth |
| JP3867215B2 (en) * | 1996-12-26 | 2007-01-10 | 株式会社大協精工 | Sealing plug for pharmaceutical container and pharmaceutical container assembly |
| US5817509A (en) * | 1997-03-19 | 1998-10-06 | Becton Dickinson And Company | Culture vessel assembly |
-
2001
- 2001-11-21 AU AU2002230459A patent/AU2002230459A1/en not_active Abandoned
- 2001-11-21 JP JP2002545125A patent/JP2004514432A/en not_active Withdrawn
- 2001-11-21 EP EP10167430.7A patent/EP2230297B1/en not_active Expired - Lifetime
- 2001-11-21 WO PCT/US2001/043718 patent/WO2002042419A2/en not_active Ceased
- 2001-11-21 EP EP01990694A patent/EP1346028A4/en not_active Withdrawn
-
2008
- 2008-08-13 JP JP2008208518A patent/JP4897752B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000056870A1 (en) | 1999-03-23 | 2000-09-28 | Biocrystal Ltd. | Cell culture apparatus and method for culturing cells |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083412A1 (en) * | 2003-03-18 | 2004-09-30 | Japan Tissue Engineering Co., Ltd | Method of cell culturing and cell sheet |
| JPWO2004083412A1 (en) * | 2003-03-18 | 2006-06-22 | 本多 裕之 | Cell culture method and cell sheet |
| JP4504920B2 (en) * | 2003-03-18 | 2010-07-14 | 裕之 本多 | Cell culture method |
| US7514256B2 (en) | 2005-02-11 | 2009-04-07 | Emilio Barbera-Guillem | Bioreactor for selectively controlling the molecular diffusion between fluids |
| US11274273B2 (en) | 2005-07-26 | 2022-03-15 | Corning Incorporated | Multilayered cell culture apparatus |
| US11905506B2 (en) | 2005-07-26 | 2024-02-20 | Corning Incorporated | Multilayered cell culture apparatus |
| EP1935974A4 (en) * | 2005-10-14 | 2012-04-25 | Toyo Seikan Kaisha Ltd | CULTURE TANK AND CULTURE METHOD |
| US11377635B2 (en) | 2006-12-07 | 2022-07-05 | Wilson Wolf Manufacturing Corporation | Highly efficient gas permeable devices and methods for culturing cells |
| US12264332B2 (en) | 2006-12-07 | 2025-04-01 | Wilson Wolf Manufacturing, LLC | Highly efficient gas permeable devices and methods for culturing cells |
| CN111548938A (en) * | 2020-06-09 | 2020-08-18 | 英诺维尔智能科技(苏州)有限公司 | New high-performance culture flask for mixed culture of suspension and adherent cells |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002230459A1 (en) | 2002-06-03 |
| JP2008295458A (en) | 2008-12-11 |
| JP4897752B2 (en) | 2012-03-14 |
| JP2004514432A (en) | 2004-05-20 |
| EP1346028A2 (en) | 2003-09-24 |
| EP1346028A4 (en) | 2008-05-28 |
| EP2230297A1 (en) | 2010-09-22 |
| WO2002042419A3 (en) | 2002-10-24 |
| EP2230297B1 (en) | 2015-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6410309B1 (en) | Cell culture apparatus and methods of use | |
| US6479252B1 (en) | Cell culture apparatus and methods of use | |
| JP4897752B2 (en) | Cell culture device and method of use | |
| US6329195B1 (en) | Cell culture apparatus | |
| US5686304A (en) | Cell culture apparatus and method | |
| AU2006335679B2 (en) | Device for culturing and transporting cells | |
| JP2010512148A (en) | Apparatus and method effective for cell culture | |
| JP3764959B2 (en) | Cell culture container and cell culture method | |
| CA2283753C (en) | Micropathological patient replica based on unadulterated whole blood | |
| JPS61108373A (en) | Cell culture apparatus and method | |
| EP3395939B1 (en) | Cell sorting, culture, and growth vessel; and cell sorting, culture, and growth method | |
| EP0735134B1 (en) | Trans-membrane co-culture insert and method for using | |
| US20070207537A1 (en) | Bioreactor | |
| US5470743A (en) | Transmembrane cell culture device | |
| JP4668568B2 (en) | Culturing container, culturing apparatus, and cell culturing method | |
| WO2002042421A2 (en) | Cell culture apparatus and methods of use | |
| JPH11509420A (en) | Dialysis multiple well tissue culture plate | |
| JP3157029U (en) | Cell experiment kit | |
| JP2002539783A (en) | Cell culture device and method for culturing cells | |
| JP2003339368A (en) | Device containing hollow fiber and use thereof | |
| EP3098304A1 (en) | Hybrid cell detachment-free cell expansion system for adherent cell culturing and related proceeding protocol | |
| WO2025228993A1 (en) | Filter for cell culture and cell culture platform thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2002 545125 Kind code of ref document: A Format of ref document f/p: F |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2001990694 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001990694 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |